FDA Inspection
Bell Pharmaceuticals, IncBell Pharmaceuticals, Inc – FDA Inspection, Apr 5, 2013
Record Details
This FDA Inspection record concerns Bell Pharmaceuticals, Inc, with an inspection on April 5, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Bell Pharmaceuticals, Inc
- Inspection Date
- April 5, 2013
- Product Type
- Drugs
View Company Profile
ID · 9d791269-7da1-43fc-8b4d-f6c365418ff2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 826998
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.122(d)Label storage access limited to authorized personnel
- 21 CFR 211.188Prepared for each batch, include complete information
- Failure of responsible person to report AE (non-RX Drug)
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bell Pharmaceuticals, Inc
5| Date | Classification | Office | Project area |
|---|---|---|---|
| June 18, 2025 | VAI | Minneapolis District Office | Drug Quality Assurance |
| April 6, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 20, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 12, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 15, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bell Pharmaceuticals, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.